BioSpace News Archive

Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN), a patient-focused clinical stage biopharmaceutical company committed to the development of innovative and impactful treatments for organ and cell transplantation, autoimmune conditions, and neurodegenerative disease, today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to tegoprubart.

PTC Therapeutics, Inc. announced the election of Alethia Young to the company’s Board of Directors.

Thermo Scientific EliA RNA Pol III and EliA Rib-P tests have been cleared by the U.S. Food & Drug Administration (FDA) for aiding in the diagnosis of Systemic Sclerosis (SSc; scleroderma) and Systemic Lupus Erythematosus (SLE).

Aptevo Therapeutics Inc. today announced new remission data on four additional patients.

Horizon Therapeutics plc (Nasdaq: HZNP) today announced that it has been recognized by Seramount (formerly Working Mother media) as a Top 75 Company for Executive Women.

Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient-focused biopharmaceutical company, today announced that it has entered into an extension of its Sponsored Research Agreement with Washington University in St. Louis.

BIORCHESTRA Co., Ltd (BIORCHESTRA), is scheduled to give a company presentation on June 16 , 12:00 at BIO International convention, taking place in San Diego, California , between June 13-16, 2022.

Global demand for interoperable technology to support clinical trial payments drives company’s monumental adoption rate; Need for patient-centric solutions reinforced by survey data.

Innovative business model preserves Vividion’s entrepreneurial culture and pipeline focus, while adding the technical expertise and resources of a global pharma leader.

Clarus Therapeutics Holdings, Inc. (“Clarus”) (Nasdaq:CRXT), today announced that new data for JATENZO (testosterone undecanoate) will be presented in the form of an abstract at ENDO 2022, the Endocrine Society’s annual meeting, taking place at the Georgia World Congress Center in Atlanta June 11-14, 2022.